Purchase Order 75N91023P00078
Award Date 12/1/22
Potential Completion Date 11/30/24
Potential Value $200K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Waltham, MA 02453, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm-fixed-price purchase order for $302,039.20 was awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to BostonGene Corporation. The contract is for targeted deep sequencing and bioinformatics analysis of 162 human plasma samples to support a clinical trial investigating the safety and efficacy of the Copanlisib/Rituximab combination treatment for previously untreated follicular lymphoma patients. The objective is to obtain plasma...
- <p>The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $17,640 purchase order to Human Metabolome Technologies America, Inc. for testing services. The firm fixed price contract will be performed in Boston, Massachusetts over a three month period concluding in October 2023. The award provides testing services in support of the National Cancer Institute's research efforts. No subcontractors or set aside designations were identified.</p>
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $23,520 purchase order to Human Metabolome Technologies America, Inc. for laboratory testing services. The firm fixed price contract has a period of performance from August 22, 2023 through November 21, 2023 for work to be conducted in Boston, Massachusetts. No subcontractors or set aside designations were identified. The award provides laboratory testing support for the National...
- <p>This is a $299,999.00 Firm Fixed Price contract awarded by the National Cancer Institute, a civilian agency, to Innogenomics Technologies, L.L.C., a minority-owned small business, under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for research and development in the area of biomedical (basic research). It was awarded on September 22, 2015 with a final completion date of March 21, 2017. The contract has a total small business set-aside designation.</p>
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute awarded a $455,000.00 Firm Fixed Price Definitive Contract to Omicscraft LLC, a minority-owned, small disadvantaged business, for a cloud-based liquid-biopsy platform to support the Cancer Research Data Commons. This contract falls under the ISYSMET program, which focuses on the development of cloud-based pipelines for integrative analysis of multi-omics and imaging data. The...
- The National Cancer Institute (NCI) awarded a $142,009.29 firm fixed-price purchase order contract to Fundacio Centre De Regulacio Genomica, a non-profit biomedical research institute, to perform targeted gene sequencing on samples collected by NCI's Division of Cancer Epidemiology and Genetics. This contract, which does not have a set-aside designation, is expected to be completed by June 2023. The contract was awarded in September 2021 under simplified acquisition procedures for commercial...
- The National Cancer Institute, a component of the Department of Health and Human Services, awarded a $489,805 firm fixed price purchase order to Biofortis, LLC. The contract provides for Biofortis Labmatrix clinical and translational research management software subscriptions, maintenance, and development support services over a base period of performance from August 2021 through August 2022. The original solicitation sought these capabilities on a sole source basis from Biofortis to provide...
- This is a $15,589.93 firm-fixed-price delivery order awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services (HHS), to Boston Medical Center Corporation (BMC), a non-profit academic medical center in Boston, Massachusetts. The contract is for CPTAC (Clinical Proteomic Tumor Analysis Consortium) task order services and does not have a set-aside designation. The order is part of a larger NCI Tissue Source Site for Tumor Analysis indefinite...
- This federal contract award, valued at $166,819,979.48, was issued by the National Cancer Institute (NCI) to The Broad Institute, Inc. (doing business as Broad Institute of MIT and Harvard), a non-profit biomedical and genomic research organization. The contract is for the Sequencing for the Cancer Genome Atlas (TCGA) Program, which supports the generation and analysis of genomic data to advance cancer research. The Broad Institute will provide a range of scientific services, including genomic...
- This federal contract award to The Broad Institute, Inc. (doing business as Broad Institute of MIT and Harvard) provides DNA characterization services to support the genomic research initiatives of several National Cancer Institute (NCI) programs, including the Cancer Genome Characterization Center, Clinical Proteomic Tumor Analysis Consortium, and Division of Cancer Epidemiology and Genetics. The $19,570,872.26 firm-fixed-price delivery order was issued under the NCI Genomic Characterization...